5.045USD-2.13%Mkt Cap: 43.40M USDP/E: —Last update: 2026-06-01
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in areas of significant unmet medical need in oncology in the United States. Its lead drug candidate is oral (Z)-endoxifen, a sele…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap43.40M USD
Enterprise Value13.32M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-34.77M USD
Revenue/Share—
Last Price5.045 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees16
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS04962H5063
Valuation
P/E (Trailing)—
P/E (Forward)-2.15
PEG—
EV/EBITDA-0.34
EV/Revenue—
P/S—
P/B1.48
EPS (TTM)-4.37
EPS (Forward)-2.44
52W Range
3.7608% of range19.35
52W High19.35 USD
52W Low3.760 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-88.35%
ROA-73.03%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-29.76M USD
CapEx (TTM)23.00K USD
FCF Margin—
FCF Yield-48.92%
Net Debt-31.72M USD
Net Debt/EBITDA0.80
Balance Sheet
Debt/Equity—
Current Ratio4.92
Quick Ratio4.25
Book Value/Sh3.540 USD
Cash/Share3.683 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateApr 20, 2018
Splits
Last Split1:15
Split DateFeb 2, 2026
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)22.75 USD
Target Range20.00 USD – 25.00 USD
# Analysts4
Ownership
Shares Out.8.61M
Float8.61M
Insiders1.41%
Institutions18.88%
Short Interest
Short Ratio5.9d
Short % Float3.97%
Short % Out.3.96%
Shares Short341.34K
Short (prev mo.)351.93K
Technical
SMA 505.298 (-4.8%)
SMA 2009.145 (-44.8%)
Beta1.25
S&P 52W Chg27.94%
Avg Vol (30d)50.90K
Avg Vol (10d)41.32K
Technical Indicators
RSI (14)48.8
MACD-0.1060
MACD Signal-0.1118
MACD Hist.+0.0057
BB Upper5.906 USD
BB Middle5.213 USD
BB Lower4.521 USD
BB Width26.57%
ATR (14)0.3124 USD
Vol Ratio (20d)0.56x